| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.5M | +17.2% |
| Cost of Revenue | $20.2M | -5.8% |
| Gross Profit | $10.3M | +124.8% |
| R&D Expense | $5.4M | -22.9% |
| SG&A Expense | $7.9M | +4.0% |
| Operating Income | -$2.9M | +70.5% |
| Pre-tax Income | -$1.1M | +78.8% |
| Net Income | -$1.1M | +78.8% |
| EPS (Basic) | -$0.01 | +85.7% |
| EPS (Diluted) | -$0.01 | +91.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | -24.1% |
| Accounts Receivable | $7.0M | +56.8% |
| Inventory | $8.7M | +14.1% |
| Current Assets | $23.9M | +15.4% |
| Total Assets | $73.1M | +42.3% |
| Current Liabilities | $7.0M | -22.1% |
| Total Liabilities | $49.3M | +48.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | +52.4% |
| Investing Cash Flow | -$19.2M | -61.4% |
| Financing Cash Flow | $20.8M | +35.1% |
| Stockholders' Equity |
| $23.8M |
| +30.4% |